WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it will report financial results for the fourth quarter and year ended December 31, 2009 on Thursday, February 11, 2010, after the U.S. financial markets close.
